PROTON STEREOTACTIC BODY RADIATION THERAPY FOR CLINICALLY CHALLENGING CASES OF CENTRALLY AND SUPERIORLY LOCATED STAGE I NON-SMALL CELL LUNG CANCER

摘要

PurposeTo minimize toxicity while maintaining tumor coverage with stereotactic body radiation therapy (SBRT) for centrally or superiorly located stage I non-small-cell lung cancer (NSCLC), we investigated passive-scattering proton therapy (PSPT) and intensity-modulated proton therapy (IMPT).